By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Women's health diagnostic test startup Sera Prognostics today said it has raised $1.4 million in a Series A-1 round, which will go toward development of a test for preterm birth risk.

Leading the A-1 round was UpStart Ventures, which founded Sera in 2008. Catalyst Health Ventures and individual investors also participated in the round. Dennis Farrar, a partner with UpStart, is the company's chairman and CEO.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Sponsored by

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.

Sponsored by

In this webinar, Michael Quail of the R&D Sequencing team at the Wellcome Trust Sanger Institute will provide an expert perspective on library prep for next-generation sequencing.

Sponsored by

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.